Breast medical oncologist & assistant professor @OSUCCC_James • #Immunoonc #Immunotherapy • Opinions expressed are my own •🇧🇴🇺🇸 • She/Her/Ella
Columbus, OH
Joined April 2009
- Tweets1.4K
- Following791
- Followers1.1K
- Likes7.8K
Dionisia Quiroga, DO, PhD, FASCO retweeted
📝New publication from @sardesai_sagar @quirogad @Nicole_O_W @StoverLab & colleagues in @JCOOA_ASCO: Episodic Future Thinking: A Behavioral Intervention to Promote Weight Loss in Breast Cancer Survivors (Alliance A21-Pilot10) #breastcancer
doi.org/10.1200/oa-26-00009
Dionisia Quiroga, DO, PhD, FASCO retweeted
👏Congratulations to our @OhioStateMedOnc physicians named as 2026 Castle Connolly Top Doctors! medicine.osu.edu/news/castle…
Another 46 miles in the bag!
Loved spending the morning with my med onc colleagues cycling to #EndCancer @Pelotonia @OSUCCC_James
Dionisia Quiroga, DO, PhD, FASCO retweeted
🟢From riding ➡️rounding today! Same goal=end cancer for our patients! 💚@Pelotonia @OSUCCC_James @jamesblachly @KimrynRathmell @quirogad @StoverLab @cindyannmarie
All be safe out there and have a blast:)!
Dionisia Quiroga, DO, PhD, FASCO retweeted
@OhioStatePIIO means collaboration and unity for a common goal, a cancer-free world! 🗺️
Great experience and energy with @OSUCCC_James team!
#Pelotonia2027 100 miles, here we come! ⚡️
@quirogad @StoverLab @nerealiamd
@ChristianRolfo
@OhioStateMedOnc turning out for @Pelotonia — riding to fund the important research that finds cures for our patients! @RobertoBoreaMD @quirogad @nerealiamd @StoverLab @ChristianRolfo
Dionisia Quiroga, DO, PhD, FASCO retweeted
Inspired by the incredible energy of the @Pelotonia community today. Every mile honors loved ones and helps fund life saving cancer research. Thank you to riders, volunteers, donors and cheers us on. Together, we’re making a difference🚴💚@OhioStateMedOnc @OSUCCC_James
#EndCancer
Dionisia Quiroga, DO, PhD, FASCO retweeted
@OhioStateMedOnc turning out for @Pelotonia — riding to fund the important research that finds cures for our patients! @RobertoBoreaMD @quirogad @nerealiamd @StoverLab @ChristianRolfo
Dionisia Quiroga, DO, PhD, FASCO retweeted
It’s ride day for @StoverLab, @quirogad, @nerealiamd & @RobertoBoreaMD —Riding to support cancer research and ultimately improve outcomes for our patients. 🚴♀️🚴🚴♂️🚴💚
Looking forward to joining Dr. @hoperugo to review some of the key highlights from #ASCO2026 and discuss how these latest advances are shaping the care of patients with breast cancer.
📅 Date: Friday, July 31
🕒 Time: 11:30 EST
Register here: deceraclinical.com/education…
Dionisia Quiroga, DO, PhD, FASCO retweeted
📢 I rarely post any more on this platform - so you know it's a big deal
Join @quirogad from @OSUCCC_James & the @NCBC_BreastCare team for a webinar focused on #IBC
@IBC_Australia @IBC_DanaFarber @TalkIBC @IBCradiation @IBCResearch @4dukeibc @BreastCanada
Inflammatory Breast Cancer (IBC) is one of the most aggressive forms of breast cancer—and it often doesn't present as a lump, leading to delayed diagnosis.
Join our educational webinar:
July 30
12 PM PT | 2 PM CT | 3 PM ET
Register: us02web.zoom.us/webinar/regi…
Dionisia Quiroga, DO, PhD, FASCO retweeted
Pelotonia 2026 is less than a week away. I hope you're joining me in this Ohio tradition, which is such an important part of the groundbreaking cancer research coming from my @OSUCCC_James colleagues each year. pelotonia.org/
Dionisia Quiroga, DO, PhD, FASCO retweeted
So excited and grateful for this new role and the opportunities for our patients; with a creative vision, newest technologies, precision, and strong collaborations with clinicians and researchers from @OSUCCC_James, the US and the world— @KimrynRathmell @Zihai @ChristianRolfo
Congrats to @AkEisfeld appointed as Director of Precision Genomics Clinical Transformation @OSUCCC_James. An internationally recognized leader in leukemia genomics & precision medicine, her expertise makes her the ideal person to lead this initiative & advance personalized care.
Dionisia Quiroga, DO, PhD, FASCO retweeted
📝New publication from Dr. Kai Johnson & colleagues in @OncJournal: Impact of Oncotype DX Risk Categorization and Receipt of Chemotherapy on Survival Outcomes Among Patients with Small Node-Negative HR+ Breast Cancer @royaryam @nerealiamd @StoverLab
doi.org/10.1093/oncolo/oyag2…
Dionisia Quiroga, DO, PhD, FASCO retweeted
Congrats to @AkEisfeld appointed as Director of Precision Genomics Clinical Transformation @OSUCCC_James. An internationally recognized leader in leukemia genomics & precision medicine, her expertise makes her the ideal person to lead this initiative & advance personalized care.
Dionisia Quiroga, DO, PhD, FASCO retweeted
Congratulations to @maryam_lustberg for winning the highest MASCC honor - the distinguished service award for 2026. Past president of MASCC and a leader in cancer supportive care! Well deserved!! @OncoAlert #MASCC26
Dionisia Quiroga, DO, PhD, FASCO retweeted
👏Congrats to our recently promoted faculty members! @AsrarAlahmadi
Dionisia Quiroga, DO, PhD, FASCO retweeted
🚨 Endocrine Therapies for #mBC
🤩 @HundalJasmin & @quirogad discuss:
👉 CDK4/6i + AI remains 1L standard for HR+ #BreastCancer
👉 Prior response & resistance guide next steps
#bcsm #OncTwitter #MedTwitter #MedX @OSUCCC_James #MedEd #FOAMed
🎥 Video👇
oncupdates.com/video-podcast…
Dionisia Quiroga, DO, PhD, FASCO retweeted
We’re asking the wrong question.
Not: “How do we train the next generation of breast cancer researchers?”
But: “Why are we making it so hard for them to stay?”
Our new international BIG–NCTN paper outlines practical solutions to support early-career investigators—from protected funding and trial leadership opportunities to mentorship, sponsorship, and equity-focused reforms.
Investing in ECIs isn’t altruism. It’s an investment in the future of cancer research—and in the patients who depend on it!
#bcsm @BCRFcure @theNCI @Seamusoreilly18 @MariyaRozenblit @nlinmd @darioT_ @io_zerdes @UNC_Lineberger @YaleBreast @DFCI_BreastOnc
nature.com/articles/s41523-0…
Dionisia Quiroga, DO, PhD, FASCO retweeted
METAvivor is devastated to report the death of Amy Beumer, former board member, from metastatic breast cancer. We will miss her brilliance, wit, and friendship. In Amy's honor, we remain committed to ending deaths from MBC. Our condolences to her family and loved ones.
What makes receiving #FASCO status even better? Doing it with amazing colleagues and Winn alumni like @TheDrWood!
@ASCO @WinnAwards @OhioStateMedOnc
